Objective: Onset of epilepsy before 2 years of age is associated with poor cognitive outcome; however, the natural course of the range of epilepsies that occur at this age is unknown. The aim of this prospective community-based study was to investigate the neuropsychological development of infants with newly diagnosed epilepsy longitudinally and to identify the clinical factors that predict long-term impairment. Methods: Sixty-six infants <24 months of age were enrolled in the baseline phase of this study; 40 were seen again at 1-year follow-up and 40 at 3-year follow-up. Children underwent a neurological and neuropsychological assessment at each time point. Results: More than 55% of children demonstrated impaired cognitive functioning at each assessment, with a similar percentage showing impaired memory and attention at 3-year follow-up. Cognitive scores obtained at each time point were correlated. More than 20 seizures/seizure clusters prior to assessment and an abnormal neurologic examination predicted poor cognitive functioning at baseline, whereas continuing seizures and baseline cognitive score predicted 3-year intelligence quotient (IQ)/cognitive score. Significance: These findings demonstrate the following: (1) infants who are performing poorly at baseline continue to display impaired development at follow-up, (2) these children are delayed across a range of neuropsychological functions, and (3) a high number of seizures close to initial diagnosis and continuing seizures at follow-up independently predict cognitive impairment. These findings help to identify those infants with new-onset epilepsy who are most at risk for poor developmental outcome and suggest that multimodal interventions should be instituted early in the course of the disorder to improve outcomes.
| INTRODUCTION
The spectrum of underlying etiologies and electroclinical phenotypes in infant-onset epilepsies is wide. [1] [2] [3] Despite this heterogeneity, a high proportion of these infants present with cognitive impairment. [3] [4] [5] [6] [7] Studies of childhood epilepsies suggest that age at onset is an important factor in predicting the level of impairment, with earlier onset associated with poorer neuropsychological functioning. [5] [6] [7] [8] [9] [10] In addition to an early age at onset, a number of factors have been associated with negative developmental outcomes such as higher seizure frequency, 5 longer seizure duration, 10 epileptic encephalopathy, 8, 11 and medicationresistant epilepsy, 7, 12 as well as abnormalities on neuroimaging/electroencephalography (EEG), abnormal neurologic examination, and a history of epileptic spasms. 4 The etiology of the seizures themselves may also underlie this poor development, as childhood studies report the presence of cognitive impairment near or at the onset of epilepsy, [13] [14] [15] [16] and etiology has been identified as a predictive factor for negative outcome. 8, 17 Due to methodologic differences, findings vary between studies as to the specific cognitive impairments and risk factors associated with early onset epilepsy. This makes it difficult to identify early those children most at risk for developmental compromise, to target intervention most effectively, and also to counsel carers appropriately about long-term outcomes. The aims of this prospective, longitudinal, community-based study of new-onset infant epilepsies were to (1) identify neurologic predictors of poor cognitive functioning close to initial diagnosis, (2) to examine the developmental trajectory of these new-onset epilepsies into early childhood, and (3) to identify neurologic predictors of later developmental outcomes.
| MATERIALS AND METHODS

| Recruitment
The recruitment methods have been described in detail previously. 1 In brief, infants between 1 and 24 months of age with newly diagnosed epilepsy (defined as recurrent unprovoked seizures), resident in 15 adjacent boroughs of North London, were identified through a survey involving community-and hospital-based pediatricians over 24 months. Infants were enrolled if they met the following inclusion criteria (1) between 4 weeks and 2 years of age, and (2) a history of 2 or more unprovoked seizures >24 hours apart. Infants were excluded if they presented with provoked seizures, that is, fever, infections, trauma, electrolyte disturbances, transient metabolic or endocrine disorders, or seizures confined only to the neonatal period.
Ethical approval for the study was received from Great Ormond Street Hospital for Children/University College London (UCL) Institute for Child Health Research Ethics Committee. All parents/carers provided written informed consent to permit their child's participation in this study.
| Participants
A total of 137 cases of new-onset epilepsy in infants <2 years of age were referred to the study. Seventy-six of these infants were assessed. No clinical or demographic information is available for those children for whom participation was declined. Ten infants were subsequently excluded, as on further review inclusion criteria were not met (7 infants presented with febrile or acute illness related seizures) or the clinical and neuropsychological information obtained at enrollment was insufficient (3 cases).
The data for the remaining 66 children (38 male, mean age 11.9 months, standard deviation [SD] 6.9) are reported here. At baseline, infants underwent a neurodevelopmental assessment after a median time interval of 8.5 weeks (interquartile range [IQR] 12 weeks) following the diagnosis of epilepsy.
Forty of these children (24 male, mean age 26 months, SD 7.9) were seen at 1-year follow-up, and an additional 40 (25 male, mean age 48.8 months, SD 7.3) at 3-year follow-up, 31 of whom were assessed at 1-year follow-up. Data from all 3 time points were available for 31 children (47%). Six of the 26 children not evaluated at 3-year follow-up had died during the follow-up period. The families of remaining children were uncontactable or declined participation.
| Neuropsychological assessment
The Bayley Scales of Infant and Toddler Development, Third Edition, 18 was administered at baseline and at 1-year 20 Children with developmental delay (23/40 children) who could not be assessed with the Leiter were assessed using the Bayley Scales. Composite cognitive scores were calculated for 7 of these children using the Bayley standardized norms. The remaining 16 children exceeded the age range of the Bayley Scales (<42 months) so composite IQ scores were calculated using the Leiter Scale, with the children receiving a score of zero on each subtest and a composite IQ score determined according to age. Cognitive age equivalents were also calculated for these 16 children using the Bayley Scales to provide an indication of the level at which these children were functioning (see Figure S1 ); age equivalents are included for reference only and were not used in any analysis. Memory and attention were assessed using the Leiter-Revised. The memory screen provides a composite memory score for the child (mean 100, SD 15), and the attention sustained subtest produces a scale score with a mean of 10 and SD of 3. Again for children who could not complete these tasks, a score of zero was assigned and a composite/scale score calculated according to age.
| Clinical evaluation
At enrollment, the parents/carers were interviewed to obtain clinical information including age at seizure onset, seizure manifestations, number of seizures or seizure clusters experienced prior to current assessment, antiepileptic medication, known medical or genetic conditions, family history, and developmental progress prior to seizure onset. Infants underwent a neurologic examination. EEG and neuroimaging data as well as investigation results were obtained. Sixty-five of the 66 cases underwent neuroimaging (64 magnetic resonance imaging [MRI], majority 1.5 Tesla systems with variable imaging protocols, performed at different institutions); one computer tomography [CT] study). Where possible, neuroimages were reviewed by neuroradiologists unaware of clinical details of cases apart from the inclusion criteria (64 of the 66 cases, 97%). Findings on neuroimages or described in imaging reports were classified as "etiologically relevant structural abnormalities" (abnormalities commonly seen in children with epilepsy), "etiologically uncertain/incidental finding" (abnormalities commonly seen in a broader range of neurologic and neurodevelopmental disorders not just associated with epilepsy), and "normal." EEG data obtained close to diagnosis or baseline assessment were available for 65 infants. EEG recordings (n = 62, 92%) or EEG reports were scored according to the presence of epileptiform discharges and abnormal background activity. Etiology was classified as unknown (n = 35), structural/metabolic (n = 26), or genetic (n = 5).
The clinical information, neuroimaging, and EEG data were reviewed independently by 2 pediatric neurologists, who verified the diagnosis of epilepsy, classified electroclinical syndromes, 21 and determined whether seizure types were "epileptic spasms" or "other seizure types." (See Table S1A ,B for information about epilepsy syndromes/epilepsy types and etiologies.) At 1-and 3-year follow-up, information about the clinical progress and medication was obtained from the carers/ parents.
| Statistical analysis
The Statistical Package for the Social Sciences (SPSS 21) for Windows was used for analyses. Univariate analysis was undertaken using Mann-Whitney and KruskalWallis for between-subjects tests and Wilcoxon signedrank test for repeated measures, with effect sizes reported as r. Categorical data were analyzed using chi-square and Fisher's exact test. For categorical data analysis, IQ/ cognitive score was transformed into 2 categories: cognitive scores ≤70, and cognitive score >70. No significant difference was found between genders on cognitive or clinical variables. Multiple linear regression analyses were conducted to identify neurologic predictors of cognitive function at baseline, and 1-and 3-year follow-up. A forced entry method was used, as other methods such as "stepwise" are prone to suppressor effects, and it can be difficult to replicate the results. 22 To protect against multicollinearity, the association between clinical predictor variables was examined using chi-square, and Cramér's Phi was used to examine the strength of the association with a cutoff value of ≥0.8 used to identify multicollinearity 22 (see Table S2 ).
| RESULTS
| Baseline assessment
At baseline assessment, 56.1% of children had a Bayley cognitive composite score ≤70, >2 SD below the mean. The cognitive composite scores were correlated highly with both the baseline Bayley language composite scores (r s = 0.777, P < 0.01) and Bayley motor composite scores (r s = 0.865, P < 0.01) (see Table 1 ). The age at epilepsy onset did not correlate with the cognitive score at baseline (r s = 0.139, P = 0.267).
All baseline, the clinical variables investigated significantly affected cognitive functioning (see Table 2 ). Because the "neuroimaging findings" clinical variable had 3 levels, dummy coding was used to investigate this as a categorical variable with 2 levels in all further analysis.
The 7 clinical variables (known etiology, >20 seizures prior to baseline assessment, interictal discharges on EEG, grossly abnormal background activity on EEG, abnormal neurologic examination, epileptic spasms, and >1 antiepileptic drug [AED]) were entered into a multiple linear regression model. "Etiologically relevant structural abnormality on MRI" was removed from the analysis due to its high association with "known etiology" (Phi 0.82). "Abnormal neurologic examination" and ">20 seizures prior to baseline assessment" emerged as significant predictors of Bayley cognitive score. Examination of the 2 predictor regression model showed that "abnormal neurologic examination" (t(60) = -5.85, P < 0.001, B = −20.3 (SE B = 3.5)) and ">20 seizures prior to baseline assessment" (t(60) = −5.06, P < 0.001, B = −18.3 (SE B = 3.6)) accounted for 65.5% of variation in Bayley cognitive composite scores (R 2 = 0.655). The sensitivity and specificity of each of the neurologic predictor variables were examined in relation to baseline cognitive functioning (see Table 3 for results). "Abnormal neurologic examination at baseline" had the highest sensitivity at 93.1%; >20 seizures prior to baseline assessment" had the greatest specificity at 90.9%.
| One-year follow-up assessment
No statistically significant difference was found between Bayley cognitive composite score at baseline assessment and 1-year follow-up (z = −0.507, P = 0.61, r = 0.08), and these scores were also highly correlated (r s = 0.772, P < 0.001). Mean cognitive score at 1-year follow-up was 71.88 (SD 21.18), with a median of 55. Sixty percent of infants assessed had a Bayley cognitive composite score ≤70. An exploratory data analysis of the baseline clinical predictor variables and age at onset in relation to Bayley cognitive score at 1-year follow-up was performed (see Table 2 ). Known etiology, >20 seizures prior to baseline assessment, interictal discharges on EEG, grossly abnormal background activity on EEG, abnormal neurologic examination, epileptic spasms, and baseline cognitive score were entered as predictors in a multiple linear regression model. Again "etiologically relevant structural abnormality on MRI" was removed from the analysis due to its high association with "known etiology" (Phi 0.95). Bayley baseline cognitive score accounted for 64.1% of variation (R 2 = 0.641) in cognitive score at 1-year follow-up (t(38) = 8.23, P < 0.001, B = 0.87 (SE B = 0.11)). None of the other clinical variables investigated were significant.
| Three-year follow-up assessment
At 3-year follow-up, 57.5% of 40 children had an IQ/cognitive score ≤70; 57.5% demonstrated attention deficits, and 66.7% displayed impairments in memory functioning (IQ/cognitive score mean 72.8, SD 31.1, median 55; memory score mean 68.9, SD 23.33, median 56; Attention score mean 5.68, SD 2.74, median = 4). Memory composite scores were highly correlated with IQ/cognitive composite scores (r s = 0.933, P < 0.001), as were the attention sustained scale scores (r s = 0.843, P < 0.001).
There was no significant difference between IQ/cognitive score at 3-year follow-up and cognitive composite score at baseline assessment (z = −0.344, P = 0.73, r = 0.05) or 1-year follow-up (z = −0.285, P = 0.78, r = 0.04). A strong correlation between IQ/cognitive score at 3-year follow-up and Bayley cognitive composite score at baseline (r s = 0.763 (40), P < 0.001) and 1-year followup (r s = 0.85 (31), P < 0.001) was found (see Figure 1) . (The proportion of participants falling within traditional IQ classification categories at each assessment point can be seen in Figure S2. ) Analysis of the baseline and 3-year clinical predictor variables and age at onset in relation to IQ/cognitive score at 3-year follow-up was performed (see Table 2 ). Baseline cognitive score, known etiology, interictal discharges on EEG, grossly abnormal background on EEG, neurologic examination baseline, >20 seizures prior to baseline assessment, and continuing seizures at 3-year follow-up were entered into a multiple linear regression model. "Etiologically relevant structural abnormality on MRI" and "AEDs at 3-year follow-up" were removed from the analysis due to the respective high association with "known etiology" (Phi 0.9) and "continuing seizures" (Phi 0.8). The initial model showed that continuing seizures and Bayley cognitive composite score at baseline best predicted IQ/cognitive score at 3-year follow-up. Examination of the 2 predictor regression model showed that these predictors accounted The sensitivity and specificity of each of the neurologic predictor variables were examined in relation to IQ/cognitive score at 3-year follow-up (see Table 3 for results).
| Attrition
Sixty-six infants took part in the baseline phase of this study. This reduced to 40 children by 3-year follow-up, giving an attrition rate of 39.4%. Children assessed at 1-and 3-year follow-up were compared to those who dropped out of the study on representation across baseline clinical variables (see Table 1 ). There was no significant difference between the groups on any variable (P > 0.05). No significant difference (P > 0.05) was found between these same groups on the baseline Bayley composite scores. A review of Table 1 shows that the proportion of male to female participants in the 3 time cohorts is roughly equivalent, as is the mean age at seizure onset. The percentage of cases represented on each of the neurologic variables across the cohorts is, again, similar.
Although the participants assessed at each follow-up appear to be similar in clinical characteristics and the above attrition analysis indicates that data are missing at random, different participants were evaluated at each follow-up period. Altogether, 31 participants from the overall cohort were assessed at both 1-and 3-year follow-up. The multiple regression models were repeated evaluating these 31 participants only to examine whether variation in participants affected findings. The results of both regression analyses identified the same predictor variables at 1-year (cognitive score at baseline (t(29) = 8.58, P < 0.001, 
| DISCUSSION
This prospective longitudinal study has demonstrated that cognitive impairment in infants with new-onset epilepsy is common, affecting over 50%, and that impairment is already present close to the initial diagnosis. Despite the trajectories of some individuals showing improvement and others deterioration over time (see Figure 1) , cognitive function at baseline correlated with that at 1 and 3 years, demonstrating that impairments identified at the onset are predominantly stable across early childhood. Previous studies have also found cognitive impairment present near or at the onset of epilepsy in childhood populations [13] [14] [15] [16] and persists over time.
14 Early age at seizure onset is reported to be a significant risk factor for impairment in memory, attention, and executive function abilities. 7 In our study, 57.5% of the children demonstrated attention deficits and 66.7% displayed impairments in memory. The memory and attention abilities of the children were highly correlated with their IQ/cognitive scores, which suggests that these abilities are in line with their general level of cognitive functioning rather than specific impairments in otherwise normally functioning children.
T A B L E 3 Sensitivity and specificity of clinical predictors in identifying cognitive impairment (scores ≤70) at baseline and 3-year follow-up At baseline, a high number of seizures/seizure clusters and an abnormal neurologic examination predicted poor cognitive functioning. At 1 year, poor cognitive functioning was predicted by low baseline cognitive score; the same was seen at 3 years, along with continuing seizures. Berg et al 12 noted that previous studies examining developmental outcomes in childhood epilepsy have been limited in their findings, as they investigated surgical candidates with refractory epilepsy rather than the full spectrum of epilepsies that occur in childhood. Our current study prospectively investigated a community-based newly diagnosed sample, where the full range of presenting epilepsies and seizure types were examined. Furthermore, observations reported by Berg et al 12 in their newly diagnosed cohort followed prospectively, showing greater cognitive impairment in children with both early seizure onset and medication-resistant epilepsy, are corroborated by our findings. Continuing seizures was a significant predictor of outcome at 3 years and was highly associated with medication use. As a result, it was not possible to include both predictors in the regression analysis. Thus, we cannot disregard the impact of continued use of medication on the development of cognitive function. Berg et al 8 also reported a high correlation between remission status and AED treatment, preventing inclusion of both factors in their regression model. Etiology, severe epilepsies-"epileptic encephalopathy," age at onset, and AED treatment were all significant predictors of cognitive outcome identified by Berg et al. Variations between our studies in the identified predictors could be explained by the broader seizure onset range of the epilepsy cohort investigated by Berg et al (1 month to 16 years). Epilepsy resulting from a known cause (symptomatic etiology) such as an underlying structural brain pathology has been associated with poor cognitive outcome in previous studies. 8, 17 Our univariate analysis showed that participants with a known etiology had significantly poorer cognitive scores than those with an unknown etiology; however, this was not a significant predictor in linear regression models. At the time our patients underwent investigations, some of the more recently used modern genetic technologies, such as next-generation sequencing analysis panels and whole-exome sequencing technologies, were not available. It is possible that genetic infant-onset epilepsies were underreported in this cohort. Further investigation of specific etiologies in relation to cognitive outcomes in these epilepsies is needed. Sixteen children who were not able to complete cognitive assessments at 3 years were assigned the lowest performance scores for their age on the IQ test. Similar strategies have been employed in previous studies. 6, 8 The composite IQ scores calculated for these children on the Leiter scale placed all children in the extremely low range of functioning, and this is not believed to underestimate the cognitive capabilities of these children considering their cognitive age equivalents ( Figure S1 ). Excluding these children may have biased the results, as the findings would not have reflected the full range of outcomes associated with infantonset epilepsy. An issue with longitudinal studies is loss to follow-up. This can make inferences inaccurate about the development of the participants over time if cohorts differ on test variables. However, the similarities between our cohorts and those children who dropped out of the study suggest that attrition was widespread across the whole group rather than from a particular subgroup of children. Furthermore, a repeat of the regression analyses for those participants with longitudinal data only (N = 31) produced the same results.
Despite the limitations, the present study provides important information as to the early natural history of infantonset epilepsy. The results indicate that later cognitive functioning can be predicted reliably close to seizure onset in infancy and that ongoing seizure activity is associated with F I G U R E 1 Longitudinal cognitive scores poor developmental outcome. This could be because the seizures are harmful or that etiologies in which seizures are difficult to control are also the etiologies that are associated with the most cognitive impairment. As it is not possible to distinguish these possibilities, optimizing seizure control should continue to be an important focus for treatment. However, it is also critical that educational and behavioral interventions are instituted early in the course of the disorder, as these interventions can have major positive cognitive effects independently of treatment of seizures. Given the high prevalence of cognitive disability reported, referral for neuropsychological assessment should be standard procedure for all infants presenting with new-onset epilepsy.
